Close Menu

NEW YORK – NanoString Technologies reported after the close of the market on Wednesday that its second quarter revenues were up 21 percent year over year, driven by a 10 percent hike in product and service revenues.

For the three months ended June 30, the company's total revenues were $30.3 million compared to $25.0 million a year ago. Analysts, on average, had expected revenues of $29 million.

Product and service revenues were up 10 percent year over year to $22.4 million compared to $20.4 million in the year-ago quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports on the struggle to meet the demand for rapid COVID-19 testing.

The Newsroom reports New Zealand is using genomics to trace the origins of its new coronavirus outbreak.

In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.

According to Bloomberg, Moderna has a $1.5 billion vaccine deal with the US to provide 100 million doses.